USMLE Step 1 & 2 Arrhythmias and ECG Interpretation
Last updated: May 2, 2026
Arrhythmias and ECG Interpretation questions are one of the highest-leverage areas to study for the USMLE Step 1 & 2. This guide breaks down the rule, the elements you need to recognize, the named traps that catch most students, and a memory aid that scales to test day. Read it once, then practice the same sub-topic adaptively in the app.
The rule
Approach every ECG with a fixed sequence: rate, rhythm (regular vs irregular), P-wave morphology and PR relationship, QRS width, and ST/T changes. The combination of QRS width (narrow <120 ms vs wide ≥120 ms), regularity, and P-wave behavior pins down nearly every tested arrhythmia. Once the rhythm is named, the management follows from hemodynamic stability — unstable patients get electricity (synchronized cardioversion or defibrillation), stable patients get pharmacology guided by mechanism.
Elements breakdown
Narrow-complex tachycardias (QRS <120 ms)
Origin above the ventricles; conduction uses the His-Purkinje system, so QRS stays narrow.
- Sinus tach: rate 100–160, P before every QRS
- AVNRT: regular, ~150–220, no visible P or pseudo-R'
- Atrial fibrillation: irregularly irregular, no P waves
- Atrial flutter: sawtooth F waves, often 2:1 at 150
- Multifocal atrial tach: ≥3 distinct P morphologies
Common examples:
- AVNRT terminated with adenosine
- AFib in a patient with mitral stenosis
Wide-complex tachycardias (QRS ≥120 ms)
Either ventricular origin or supraventricular with aberrancy/bundle branch block; assume VT until proven otherwise.
- Monomorphic VT: regular, uniform wide QRS
- Polymorphic VT/torsades: twisting axis, long QT trigger
- SVT with aberrancy: prior BBB pattern matches
- VFib: chaotic, no organized QRS
- AV dissociation favors VT
Common examples:
- Torsades after IV ondansetron with hypoK
- VT after old MI scar
Bradyarrhythmias and AV blocks
Failure of impulse generation (sinus node) or conduction (AV node, His-Purkinje).
- Sinus brady: rate <60, normal P-QRS
- 1° AV block: PR >200 ms, all P conduct
- 2° Mobitz I: progressive PR lengthening, drop
- 2° Mobitz II: constant PR, sudden dropped QRS
- 3° (complete) block: AV dissociation, escape rhythm
Common examples:
- Mobitz II after anterior MI → pacemaker
- Complete heart block in Lyme carditis
Pre-excitation and channelopathies
Accessory pathways or inherited ion-channel defects that create characteristic ECG signatures.
- WPW: short PR, delta wave, wide QRS
- Long QT: QTc >480 ms (♀) or >460 ms (♂)
- Brugada: coved ST elevation V1–V2, RBBB-like
- ARVC: epsilon wave, T inversion V1–V3
Common examples:
- WPW with AFib → procainamide, avoid AV-nodal blockers
- Congenital LQTS in a teen with exertional syncope
Common patterns and traps
The Width-Regularity Grid
USMLE rhythm questions almost always resolve into one of four boxes formed by QRS width (narrow vs wide) crossed with regularity (regular vs irregular). Narrow-regular includes sinus tach, AVNRT, atrial flutter with fixed conduction. Narrow-irregular is dominated by AFib, atrial flutter with variable block, and MAT. Wide-regular is monomorphic VT or SVT-with-aberrancy. Wide-irregular is polymorphic VT/torsades or AFib with WPW or aberrancy. Locating the strip on the grid is the first move and usually 80% of the answer.
The vignette gives a rhythm strip description and asks which arrhythmia is present; the right choice is the one matching that exact box on the grid.
Stable-vs-Unstable Fork
For any tachyarrhythmia or bradyarrhythmia, USMLE branches management on signs of instability: hypotension, altered mental status, ischemic chest pain, or acute heart failure. Unstable tachy with a pulse → synchronized cardioversion; pulseless VT or VF → unsynchronized defibrillation; unstable brady → atropine, then pacing. Stable rhythms get rhythm-specific drugs (adenosine for AVNRT, amiodarone or procainamide for stable VT, rate control for AFib).
Distractor offers a pharmacologic agent that is correct for a stable version of the same rhythm, but the vignette flags instability — making electricity the right answer.
The WPW-with-AFib Trap
A patient with prior pre-excitation now develops AFib, producing an irregularly irregular wide-complex tachycardia, often with bizarre, varying QRS widths. The classic mistake is reaching for an AV-nodal blocker (adenosine, beta-blocker, diltiazem, digoxin) — these block the AV node and force conduction down the accessory pathway, accelerating the ventricular rate and risking VF. Correct stable management is procainamide or ibutilide; unstable management is synchronized cardioversion.
Young patient, prior delta wave, now wide-irregular tachy at 220; the wrong choice is metoprolol or diltiazem, the right choice is procainamide or cardioversion.
The Mobitz I vs Mobitz II Pacemaker Decision
Both are second-degree AV block, but their prognosis and management differ sharply. Mobitz I (Wenckebach) shows progressive PR lengthening before a dropped beat, usually reflects AV-nodal disease, is often benign, and rarely needs pacing unless symptomatic. Mobitz II shows constant PR with sudden dropped beats, reflects His-Purkinje disease, and progresses unpredictably to complete block — it always warrants permanent pacemaker placement.
Asymptomatic patient with progressive PR lengthening — observation is correct; the trap distractor recommends pacemaker.
The Long-QT Drug Stack
Torsades de pointes appears on USMLE when an at-risk patient (female, hypoK, hypoMg, congenital LQTS, bradycardia) is given a QT-prolonging drug. Common offenders: macrolides, fluoroquinolones, antipsychotics (haloperidol, ziprasidone), methadone, ondansetron, class IA and III antiarrhythmics. Acute treatment is IV magnesium even if the magnesium level is normal, plus removal of the offending agent and correction of electrolytes; refractory cases get overdrive pacing or isoproterenol.
Hospitalized patient on multiple QT-prolonging drugs has a syncopal episode with polymorphic VT; the right answer is IV magnesium.
How it works
Suppose Mr. Reyes, 68, comes in with palpitations and a heart rate of 156. You start the algorithm: is the QRS narrow or wide? Narrow. Is it regular? Irregularly irregular, with no discernible P waves — that pattern locks in atrial fibrillation. Now move to management: blood pressure 138/80 and he is mentating well, so he is stable. Stable AFib with rapid ventricular response gets rate control (a beta-blocker or non-dihydropyridine calcium channel blocker), anticoagulation decision via CHA₂DS₂-VASc, and consideration of rhythm control later. If instead his pressure had been 70/40 with chest pain and altered mentation, the algorithm short-circuits to synchronized cardioversion. The same scaffold — width, regularity, P behavior, then stability — solves the next-best-step regardless of whether the rhythm is AVNRT, VT, or complete heart block.
Worked examples
Which of the following is the most appropriate next step in management?
- A Immediate synchronized cardioversion at 120 J
- B Intravenous adenosine 6 mg rapid push
- C Intravenous metoprolol for rate control ✓ Correct
- D Intravenous amiodarone bolus followed by infusion
Why C is correct: Ms. Liu has new-onset atrial fibrillation with rapid ventricular response and is hemodynamically stable (normal blood pressure, no chest pain, no altered mentation, no heart failure signs). Stable AFib with RVR is managed with rate control using a beta-blocker like IV metoprolol or a non-dihydropyridine calcium channel blocker such as diltiazem. Anticoagulation and a long-term rhythm-vs-rate strategy are addressed after acute control.
Why each wrong choice fails:
- A: Synchronized cardioversion is reserved for unstable AFib with hypotension, ischemic chest pain, altered mentation, or acute heart failure. She is hemodynamically stable, so electrical therapy is premature and exposes her to the embolic risk of unanticoagulated cardioversion in AFib of uncertain duration. (Stable-vs-Unstable Fork)
- B: Adenosine is the drug of choice for terminating AVNRT, a regular narrow-complex tachycardia. In AFib it will only briefly unmask the underlying fibrillatory pattern at the AV node and will not control the rate or convert the rhythm. (The Width-Regularity Grid)
- D: Amiodarone is a rhythm-control agent and is reasonable in selected unstable patients or those with depressed LV function, but for stable AFib with RVR and no structural heart disease information, first-line is rate control with a beta-blocker. Amiodarone also risks pharmacologic cardioversion in someone whose AFib duration and anticoagulation status are unclear.
Which of the following is the most appropriate pharmacologic therapy for his current rhythm?
- A Intravenous diltiazem
- B Intravenous adenosine
- C Intravenous procainamide ✓ Correct
- D Intravenous digoxin
Why C is correct: His baseline ECG shows the classic short PR, delta wave, and wide QRS of Wolff-Parkinson-White syndrome. He has now developed atrial fibrillation conducting down the accessory pathway, producing an irregularly irregular wide-complex tachycardia. Procainamide blocks the accessory pathway and is the preferred pharmacologic agent in stable WPW with AFib; AV-nodal blockers are contraindicated because they push more impulses down the bypass tract and can precipitate ventricular fibrillation.
Why each wrong choice fails:
- A: Diltiazem blocks the AV node, which in WPW with AFib increases the proportion of atrial impulses traveling down the accessory pathway and can accelerate the ventricular rate into VF. It is explicitly contraindicated in this scenario. (The WPW-with-AFib Trap)
- B: Adenosine produces transient AV-nodal block and, like other AV-nodal blockers, can precipitate degeneration to VF in WPW with AFib by favoring accessory-pathway conduction. It also will not terminate AFib. (The WPW-with-AFib Trap)
- D: Digoxin slows AV-nodal conduction and shortens the accessory pathway refractory period, a doubly bad combination in WPW that increases the ventricular rate and risk of sudden death. (The WPW-with-AFib Trap)
Which of the following is the most appropriate immediate intervention?
- A Intravenous magnesium sulfate ✓ Correct
- B Intravenous amiodarone
- C Intravenous metoprolol
- D Unsynchronized defibrillation at 200 J
Why A is correct: This is torsades de pointes precipitated by a long QT (QTc 510 ms) in the setting of QT-prolonging drugs (levofloxacin, ondansetron) plus hypokalemia and hypomagnesemia. Intravenous magnesium sulfate is first-line acute therapy regardless of the serum magnesium level; offending drugs should be stopped and potassium and magnesium repleted aggressively. Refractory cases benefit from overdrive pacing or isoproterenol to shorten the QT.
Why each wrong choice fails:
- B: Amiodarone itself prolongs the QT interval and can worsen torsades; it is contraindicated in polymorphic VT associated with long QT. It is reasonable for monomorphic VT, which this is not. (The Long-QT Drug Stack)
- C: Beta-blockers are the chronic therapy for congenital long-QT syndrome, but they are not the acute antidote in drug-induced torsades. Magnesium acts faster and corrects the immediate substrate.
- D: Defibrillation is appropriate for sustained torsades that does not self-terminate or for pulseless VT/VF; this episode self-terminated and the patient is now perfusing with stable vitals, so the priority is preventing recurrence with magnesium and electrolyte correction. (Stable-vs-Unstable Fork)
Memory aid
Rhythm interpretation in 5 letters: **R-R-P-Q-S** — Rate, Regularity, P waves, QRS width, ST/T. Then ask one question for management: stable or unstable? Unstable + tachy with pulse → synchronized cardioversion; unstable + pulseless VT/VF → defibrillate; unstable brady → atropine, then transcutaneous pacing.
Key distinction
AFib with rapid response is irregularly irregular with no P waves; AVNRT is perfectly regular at 150–220 with hidden or pseudo-R' P waves. Both are narrow-complex, but adenosine terminates AVNRT and only transiently slows AFib — the regularity is the giveaway.
Summary
Width plus regularity plus P-wave behavior names the arrhythmia; hemodynamic stability picks electricity vs drugs.
Practice arrhythmias and ecg interpretation adaptively
Reading the rule is the start. Working USMLE Step 1 & 2-format questions on this sub-topic with adaptive selection, watching your mastery score climb in real time, and seeing the items you missed return on a spaced-repetition schedule — that's where score lift actually happens. Free for seven days. No credit card required.
Start your free 7-day trialFrequently asked questions
What is arrhythmias and ecg interpretation on the USMLE Step 1 & 2?
Approach every ECG with a fixed sequence: rate, rhythm (regular vs irregular), P-wave morphology and PR relationship, QRS width, and ST/T changes. The combination of QRS width (narrow <120 ms vs wide ≥120 ms), regularity, and P-wave behavior pins down nearly every tested arrhythmia. Once the rhythm is named, the management follows from hemodynamic stability — unstable patients get electricity (synchronized cardioversion or defibrillation), stable patients get pharmacology guided by mechanism.
How do I practice arrhythmias and ecg interpretation questions?
The fastest way to improve on arrhythmias and ecg interpretation is targeted, adaptive practice — working questions that focus on your specific weak spots within this sub-topic, getting immediate feedback, and revisiting items you missed on a spaced-repetition schedule. Neureto's adaptive engine does this automatically across the USMLE Step 1 & 2; start a free 7-day trial to see your sub-topic mastery climb in real time.
What's the most important distinction to remember for arrhythmias and ecg interpretation?
AFib with rapid response is irregularly irregular with no P waves; AVNRT is perfectly regular at 150–220 with hidden or pseudo-R' P waves. Both are narrow-complex, but adenosine terminates AVNRT and only transiently slows AFib — the regularity is the giveaway.
Is there a memory aid for arrhythmias and ecg interpretation questions?
Rhythm interpretation in 5 letters: **R-R-P-Q-S** — Rate, Regularity, P waves, QRS width, ST/T. Then ask one question for management: stable or unstable? Unstable + tachy with pulse → synchronized cardioversion; unstable + pulseless VT/VF → defibrillate; unstable brady → atropine, then transcutaneous pacing.
What's a common trap on arrhythmias and ecg interpretation questions?
Calling irregularly irregular wide-complex "VT" instead of AFib with WPW or aberrancy
What's a common trap on arrhythmias and ecg interpretation questions?
Giving adenosine or a beta-blocker for WPW with AFib (accelerates accessory-pathway conduction)
Ready to drill these patterns?
Take a free USMLE Step 1 & 2 assessment — about 25 minutes and Neureto will route more arrhythmias and ecg interpretation questions your way until your sub-topic mastery score reflects real improvement, not luck. Free for seven days. No credit card required.
Start your free 7-day trial